Aim Speciality Health is categorized under Health Information and Referral Programs in Chicago, IL .
Aim Speciality Health was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Health Information and Referral Programs business, which does work in the B2C market, and is classified as a Health Information and Referral Programs, under code number 6219991 by the NAICS.
If you are seeking more information, feel free to contact at the company’s branch by writing to 8600 West Bryn Mawr Avenue # 800s, Chicago, Illinois IL 60631 or by phoning (773) 380-0195. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Aim Speciality Health |
Address: | 8600 West Bryn Mawr Avenue # 800s, Chicago, Illinois 60631 |
Phone Number: | (773) 380-0195 |
Website Address: | aimspecialtyhealth.com |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Location Type: | Branch |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Health Information and Referral Programs |
SIC Code: | 8099 |
NAICS Code: | 6219991 |
Share This Business: |
Aim Speciality Health was started in 0 to provide professional Health Information and Referral Programs under the SIC code 8099 and NAICS code 6219991. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact for inquiries that concern Aim Speciality Health by calling the company number (773) 380-0195, as your correspondence is most welcome. Additionally, the physical location of the branch of Aim Speciality Health can be found at the coordinates 41.981065,-87.841483 as well as the street address 8600 West Bryn Mawr Avenue # 800s in Chicago, Illinois 60631.
For its online presence, you may visit Aim Speciality Health’s website at aimspecialtyhealth.com and engage with its social media outlets through on Twitter and on Facebook.